SKLB1028

· CSPC ZhongQi Pharmaceutical Technology Co., Ltd.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for SKLB1028, covering 2016-08-09 to 2021-11-02. Get the full timeline:

Most recent: Clinical Trial Update: A Study of SKLB1028 Versus Salvage Chemotherapy in Patients With Relapsed or Refractory (R/R) AML With FLT3-Mutated [Phase 3]

See pricing